Vivos Therapeutics, Inc. (NASDAQ: VVOS) is an innovative medical technology company focused on the development and commercialization of screening and treatment for obstructive sleep apnea (OSA). Vivos offers a multidisciplinary treatment protocol that uses nonsurgical, noninvasive, and cost-effective oral appliance technology prescribed by trained dentists and medical professionals to treat dentofacial anomalies and/or mild to moderate OSA. This revolutionary treatment is called the Vivos Method.
Combining technologies and protocols that alter the size, shape, and position of the tissues of the upper airway, the Vivos Method opens airway space and can significantly reduce or even eliminate the symptoms and conditions associated with mild to moderate OSA.
read more
Vivos Therapeutics, Inc Ranks 1st in Overall Culture Score
4 Employees rate Vivos Therapeutics, Inc's Overall Culture a 92/100, which ranks it 1st against its competitors. Overall Culture scores are aggregated from all of the questions employees at a company answer on Comparably.